2Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
3Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
4The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.
5The PRISM study investigators.A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina[J].N Engl J Med,1998,338:1498-1505.
6PRISM-PLUS study investigators.Inhibition of the platelet glycoprotein Ⅱ b/Ⅲa receptor with Tirofiban in unstable angina and non-Q-wave myocardial infarction[J].N EnglJ Med,1998,338:1488-1497.
7Restore investigators.Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on aderse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty[J].Circulation,1997,96:1443-1455.
8Restore Investigators.Six month angiogrphic and linical follow-up patients prospectively randomised to receive either tirofiban or placebo during angioplasty in the RESTORE Trial[J].J Am Col Cardiol,1998,32:28-34.
9Tan K,Sulke N.Clinical and lesion morphology and the pathogenesis of unstable angina pectoris[J].J Am Coll Cardiol,1985,5:609 -616.
